Growing as a Trusted, Dedicated Commercial Biologics CDMO

On Pharma's Almanac's Road to 50 States trip, Nick Green, Chief Exceutive Officer at Avid Bioservices, met with Nigel to talk about the company's growth in the last year and why he sees cell and gene therapy as the next big thing in pharma.

Nicholas Green

Nick currently serves as President & CEO of Avid Bioservices and previously served in senior executive roles for several contract manufacturing organizations and life sciences companies, including President & CEO of Therapure Biopharma and Evolve Biologics, Managing Director of Nipa Laboratories Ltd, Head of the Life Sciences Division of Clariant International Ltd, President and CEO of Rhodia Pharma Solutions and President of Codexis Pharma Division. Up until recently Nick was also a Board Member at Induce Biologics Inc and Redrock Regeneration. Nick holds a BSc (Hons) in chemistry from Queen Mary University of London and an MBA from the University of Huddersfield in the UK.